| Class 2 Device Recall The AccuChek Aviva Plus Test Strips | |
Date Initiated by Firm | December 11, 2019 |
Create Date | February 05, 2020 |
Recall Status1 |
Terminated 3 on July 08, 2022 |
Recall Number | Z-0998-2020 |
Recall Event ID |
84518 |
510(K)Number | K131029 |
Product Classification |
System, test, blood glucose, over the counter - Product Code NBW
|
Product | Accu-Chek Aviva Plus Retail Strips 50 ct - intended for Blood Glucose Monitoring System
Catalog Number: 06908217001 |
Code Information |
Lot Number:498315 NDC: 65702-0407-10 UPC: 3-65702-40710-7 |
Recalling Firm/ Manufacturer |
Roche Diabetes Care, Inc. 9115 Hague Rd Indianapolis IN 46256-1025
|
For Additional Information Contact | Amy Lynn 317-521-0251 |
Manufacturer Reason for Recall | Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions |
FDA Determined Cause 2 | Process control |
Action | Roche Diabetes Care issued Urgent Medical Device Corrections via UPS Ground mail to the patients and distributors on 12/11/2019. Letter states reason for recall, health risk and action to take: Immediately discontinue using test strip lots 497864 and 498315. Affected test strips must be discarded. To get replacement test strips, or for questions regarding this notification, use one of the following options:
For fastest replacement of your product, please submit your request at https://notices.accu-chek.com.
Email Accu-Chek Customer Care at accu-chek.care@roche.com and include the following information: your name, full mailing address, phone number, test strip lot number and number of affected test strip vials.
o Contact our Accu-Chek Customer Care line at 1-800-358-4866 Monday through Friday between the hours of 8:00 am and 8:00 pm Eastern Standard Time.
If a Business Reply Form was included with this notification, please complete and return it by U.S. mail using the provided postage paid envelope.
Please keep this notification for future reference.
Distributors/Suppliers instructed as follows:
Discontinue distribution and destroy any remaining stock of the affected lots (497864 and 498315) immediately. make this notification available to consumer customers to whom you distributed affected product.
If you have distributed affected product to other suppliers, provide a copy of this UMDC to those suppliers. Have those customers report the quantity of product destroyed to you. |
Quantity in Commerce | 92,836 vials |
Distribution | Nationwide:
Foreign: Austalia, India |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = NBW
|
|
|
|